The ILS MIT SBIR aimed at developing an in vitro alternative to the in vivo comet assay was one of four “Papers of the Month” recognized in February’s NIEHS Environmental Factor.
Congratulations to ILS Vice President of Research and Development, Dr. Les Recio, Ph.D., DABT and ILS Director of In Vitro [...]
ILS was honored to sponsor the International Academy of Toxicologic Pathology/Society of Toxicologic Pathology (IATP/STP) Maronpot Guest Lecture Series. In addition the IATP/STP Toxicologic Pathology Trainee award was sponsored by Telikicherla Higher Education (THE) Foundation, established by Dr. Tk Rao in honor of his grandfather.
ILS Staff Toxicologist, Dr. Agnes Karmaus presented her poster at the Annual SOT Meeting in Baltimore last week. Dr. Karmaus’ poster was recognized as being among the top ten in risk assessment abstracts at the meeting alongside Dr. Shannon Bell, Dr. David Allen and co-authors for their abstract titled “Adding context to Tox21/ToxCast data: linking in vitro assays to toxicity outcomes.”
ILS is proud to announce that Dr. Les Recio, Vice President of Research and Development, has received recognition by the American College of Toxicology (ACT) for his paper, “Impact of Acrylamide on Calcium Signaling and Cytoskeletal Filaments in Testes From F344 Rat” as the Best Paper published in the International Journal of Toxicology in 2017! The award was presented at the ACT awards luncheon during the ACT annual meeting in West Palm Beach, FL, on Monday, November 5, 2018. Congratulations to Dr. Recio and co-author Tim Maynor on this outstanding achievement!
Publication titled “Impact of Acrylamide on Calcium Signaling and Cytoskeletal Filaments in Testes From F344 Rat” has been recognized by the American College of Toxicology as the Best Paper published in the International Journal of Toxicology in 2017
Congratulations to Dr. Les Recio, Vice President of Research and Development at ILS and to the co-authors of the publication [...]
The Genetics and Environmental Mutagenesis Society (GEMS) 2019 Annual Fall Meeting, Translational Relevance of Non-Genotoxic Modes of Carcinogenicity, will be held this Wednesday, October 30th at the Hamner Conference Center in Durham, North Carolina from 8am-4:30pm. Dr. Carol Swartz, ILS’ Director of In Vitro Toxicology and Formulations and GEMS current President, will be welcoming you to the conference. To register follow the link below.
Dr. Kyathanahalli Janardhan, an ILS Investigative Pathologist, participated in a podcast to discuss his publication titled “Do GISTs Occur in Rats and Mice? Immunohistochemical Characterization of Gastrointestinal Tumors Diagnosed as Smooth Muscle Tumors in The National Toxicology Program.” The link to the podcast is included below.
Dr. Kamel Mansouri, Lead Computational Chemist at ILS, presented an overview of the Collaborative Acute Toxicity Modeling Suite (CATMoS) to the Scientific Advisory Committee on Alternative Toxicological Methods at their meeting in Arlington, Virginia last month. CATMoS generates acute toxicity predictions for chemicals based on a consensus of 139 computational models developed by a consortium of 35 participants. Check out a photo from the event below.